| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8445063 | European Journal of Cancer | 2013 | 10 Pages |
Abstract
These data demonstrate that IRF-1 is up-regulated by CDDP in ovarian cancer cells and might limit the cell response to CDDP, likely by inhibiting cell proliferation. Data suggest that IRF-1 induction might interfere with the effectiveness of combination therapy with platinum drugs and cytokines.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Simona Pavan, Martina Olivero, Davide Corà , Maria Flavia Di Renzo,